Morgan Stanley Reiterates Overweight Rating on Mirum Pharmaceuticals (MIRM) amid study enrollment, screening completion

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. GNK
6. HTFL
7. SNDK
8. WDAY
9. ADYEN:NA
10. DVLT

Go back to Morgan Stanley Reiterates Overweight Rating on Mirum Pharmaceuticals (MIRM) amid study enrollment, screening completion
(NASDAQ: MIRM) Delayed: 100.64 +1.87 (1.89%)
Previous Close $98.77    52 Week High $ 
Open $98.03    52 Week Low $ 
Day High $101.31    P/E N/A 
Day Low $96.73    EPS $ 
Volume 503,793